To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The Australian biotechnology ...
Gland Pharma, Somerset Therapeutics, Odin Pharmaceuticals and two Qilu companies were hit with a patent infringement lawsuit on Nov. 13 in Delaware District Court over their proposed generic versions ...
CSL shares are down roughly 40% since acquiring Vifor in August 2022, an iron deficiency and kidney disease business and the largest acquisition in its history. However, several other factors have ...
ST. GALLEN, Switzerland, and SAN DIEGO, Sept. 26, 2025 /PRNewswire/ -- CSL Vifor and Travere Therapeutics, Inc., (NASDAQ: TVTX) support the recent publication of the updated clinical practice ...
Xiromed Pharma España and Xiromed LLC were sued for patent infringement on Nov. 21 in New Jersey District Court over their proposed generic version of the iron deficiency drug Injectafer. The action, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results